参考文献/References:
[1] Tran B. Assessment and management of peripheral arterial disease:what every cardiologist should know[J]. Heart,2021,107(22):1835-1843.
[2] Perl L,Bental T,Vaknin-Assa H,et al. Independent impact of peripheral artery disease on percutaneous coronary intervention[J]. J Am Heart Assoc,2020,9(24):e017655.
[3] Heidemann F,Kuchenbecker J,Peters F,et al. A health insurance claims analysis on the effect of female sex on long-term outcomes after peripheral endovascular interventions for symptomatic peripheral arterial occlusive disease[J]. J Vasc Surg,2021,74(3):780-787.e7.
[4] Bauersachs R,Zeymer U,Brière JB,et al. Burden of coronary artery disease and peripheral artery disease:a literature review[J]. Cardiovasc Ther,2019,2019:8295054.
[5] Sadrzadeh Rafie AH,Stefanick ML,Sims ST,et al. Sex differences in the prevalence of peripheral artery disease in patients undergoing coronary catheterization[J]. Vasc Med,2010,15(6):443-450.
[6] 胡盛寿,高润霖,刘力生,等. 《中国心血管病报告2018》概要[J]. 中国循环杂志,2019,34(3):209-220.
[7] Chan AW. Expanding roles of the cardiovascular specialists in panvascular disease prevention and treatment [J]. Can J Cardiol,2004,20(5):535-544.
[8] James JM,Mukouyama YS. Neuronal action on the developing blood vessel pattern[J]. Semin Cell Dev Biol,2011,22(9):1019-1027.
[9] Kaminsky LA,German C,Imboden M,et al. The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease[J]. Prog Cardiovasc Dis,2022,70:8-15.
[10] Fagerberg B,Barrgard L. Review of cadmium exposure and smoking-independent effects on atherosclerotic cardiovascular disease in the general population[J]. J Intern Med,2021,290(6):1153-1179.
[11] Holder TA,Gutierrez JA,Aday AW. Medical management of peripheral artery disease[J]. Cardiol Clin,2021,39(4):471-482.
[12] Ding N,Sang Y,Chen J,et al. Cigarette smoking,smoking cessation,and long-term risk of 3?major?atherosclerotic diseases[J]. J Am Coll Cardiol,2019,74(4):498-507.
[13] 董亚兰,胡德胜. 动脉粥样硬化的炎症应答特征及运用[J]. 中国动脉硬化杂志,2022,30(4):1-16.
[14] Li Y,Teng D,Shi X,et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association:national cross sectional study[J]. BMJ,2020,369:m997.
[15] Takahara M. Diabetes mellitus and lower extremity peripheral artery disease[J]. JMA J,2021,4(3):225-231.
[16] Naito R,Miyauchi K. Coronary artery disease and type 2 diabetes mellitus[J]. Int Heart J,2017,58(4):475-480.
[17] Costantino S,Paneni F,Cosentino F. Ageing,metabolism and cardiovascular disease[J]. J Physiol,2016,594(8):2061-2073.
[18] Schiele F,Ecarnot F,Chopard R. Coronary artery disease:risk stratification and patient selection for more aggressive secondary prevention[J]. Eur J Prev Cardiol,2017,24(3_suppl):88-100.
[19] Fowkes FGR,Aboyans V,Fowkes FJI,et al. Peripheral artery disease:epidemiology and global perspectives[J]. Nat Rev Cardiol,2017,14(3):156-170.
[20] Malakar AK,Choudhury D,Halder B,et al. A review on coronary artery disease,its risk factors,and therapeutics[J]. J Cell Physiol,2019,234(10):16812-16823.
[21] 许鸣笛,汪莲开,张莉,等. 血脂异常与冠心病关系的研究进展[J]. 世界最新医学信息文摘,2018,18(16):149-150.
[22] Bevan GH,White Solaru KT. Evidence-based medical management of peripheral artery disease[J]. Arterioscler Thromb Vasc Biol,2020,40(3):541-553.
[23] Kumar A,Bano S,Bhurgri U,et al. Peripheral artery disease as a predictor of coronary artery disease in patients undergoing coronary angiography[J]. Cureus,2021,13(5):e15094.
[24] Narula N,Olin JW,Narula N. Pathologic disparities between peripheral artery disease and coronary artery disease[J]. Arterioscler Thromb Vasc Biol,2020,40(9):1982-1989.
[25] Ishihara T,Yamaji K,Iida O,et al. Impact of peripheral artery disease on short-term outcomes after percutaneous coronary intervention:a report from Japanese nationwide registry[J]. PloS One,2020,15(10):e0240095.
[26] Xenogiannis I,Gkargkoulas F,Karmpaliotis D,et al. The impact of peripheral artery disease in chronic total occlusion percutaneous coronary intervention (insights from PROGRESS-CTO registry)[J]. Angiology,2020,71(3):274-280.
[27] Manfrini O,Amaduzzi PL,Cenko E,et al. Prognostic implications of peripheral artery disease in coronary artery disease[J]. Curr Opin Pharmacol,2018,39:121-128.
[28] Serruys PW,Hara H,Garg S,et al. Coronary computed tomographic angiography for complete assessment of coronary artery disease:JACC State-of-the-Art Review[J]. J Am Coll Cardiol,2021,78(7):713-736.
[29] Shamaki GR,Markson F,Soji-Ayoade D,et al. Peripheral artery disease:a comprehensive updated review[J]. Curr Probl Cardiol,2021:101082.
[30] Hur KY,Jun JE,Choi YJ,et al. Color Doppler ultrasonography is a useful tool for diagnosis of peripheral artery disease in type 2 diabetes mellitus patients with ankle-brachial index 0.91 to 1.40[J]. Diabetes Metab J,2018,42(1):63-73.
[31] Catella J,Long A,Mazzolai L. What is currently the role of TcPO2 in the choice of the amputation level of lower limbs? A comprehensive review[J]. J Clin Med,2021,10(7):1413.
[32] Tsioufis C,Andrikou I,Siasos G,et al. Anti-hypertensive treatment in peripheral artery disease[J]. Curr Opin Pharmacol,2018,39:35-42.
[33] Rodionov RN,Peters F,Marschall U,et al. Initiation of SGLT2 inhibitors and the risk of lower extremity minor and major amputation in patients with type 2 diabetes and peripheral arterial disease:a health claims data analysis[J]. Eur J Vasc Endovasc Surg,2021,62(6):981-990.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(8):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(8):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(8):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(8):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(8):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(8):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]刘欢,王宏宇.应用踝臂指数检测四肢动脉疾病疗效[J].心血管病学进展,2015,(5):563.[doi:10.3969/j.issn.1004-3934.2015.05.010]
LIU Huan,WANG Hongyu.Effect of Detection of Arterial Diseases on Extremities by Ankle Brachial Index[J].Advances in Cardiovascular Diseases,2015,(8):563.[doi:10.3969/j.issn.1004-3934.2015.05.010]
[8]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(8):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[9]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(8):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[10]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]